Neo Ivy Capital Management Seagen Inc. Transaction History

Neo Ivy Capital Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$108.81 - $179.33 $75,731 - $124,813	696 Added 8700.0%	704 $124,000
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $252,496 - $333,221	-2,111 Reduced 99.62%	8 $2,000
Q4 2021 Feb 15, 2022	BUY	$142.57 - $190.86 $302,105 - $404,432	2,119 New	2,119 $327,000
Q2 2021 Aug 16, 2021	SELL	$135.08 - $161.1 $121,166 - $144,506	-897 Closed	0 $0
Q1 2021 Oct 07, 2021	BUY	$137.51 - $190.8 $26,126 - $36,252	190 Added 26.87%	897 $125,000
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $116,393 - $149,834	707 New	707 $124,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.